** Shares of life sciences and diagnostics supplier
Sartorius SATG_p.DE up 7.83% and Sartorius Stedim Biotech
STDM.PA up 6.21% on Tuesday after their peer Danaher DHR.N
reported its Q1 results
** DHR beat quarterly profit and sales expectations, driven
by strength in its diagnostics and bioprocessing businesses
** DHR is up more than 6% in today's trading
** Taking into account today's rise of SATG, the stock has
fallen 11.61% YTD
(Reporting by Mateusz Dobrzyniewski)
((Mateusz.dobrzyniewski@thomsonreuters.com))